Equities researchers at StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock.
22nd Century Group Price Performance
XXII opened at $0.10 on Friday. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09. The stock has a fifty day moving average of $0.14 and a 200-day moving average of $0.51. 22nd Century Group has a fifty-two week low of $0.08 and a fifty-two week high of $5.28. The company has a market capitalization of $4.59 million, a P/E ratio of 0.00 and a beta of 1.45.
22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%. The business had revenue of $5.95 million during the quarter.
Hedge Funds Weigh In On 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Stories
- Five stocks we like better than 22nd Century Group
- Short Selling: How to Short a Stock
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 11/25 – 11/29
- What is a buyback in stocks? A comprehensive guide for investors
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.